RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ROSSI FG
Collezione AOU Alessandria

Items : 3

Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial. in British journal of haematology / Br J Haematol. 2025 Feb;206(2):556-564. doi: 10.1111/bjh.19920. Epub 2024 Nov 27.

2025
AOU Alessandria
AOU Città della Salute di Torino

Ferrero S; Freilone R; Varettoni M; Tani M; Merli M; Sartori R; Musuraca G; Tosi P; Pietrantuono G; Mannina D; Caravita di Toritto T; Ferrante M; Gaidano G; Rossi FG; Conconi A; Dessi D; Califano C; Curreli L; Cavallo F; Boccomini C; Monaco F; Villivà N; Castiglione A; Drandi D; Benevolo G;

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
AOU Alessandria
AOU Città della Salute di Torino

Bertoni F; Cavalli F; Landi F; Spina M; Re F; Pietrantuono G; Merli M; Houot R; Liberati AM; Haioun C; Devizzi L; Cartron G; Casasnovas RO; Angrilli F; Occhini U; Pulsoni A; Celli M; Califano C; Capochiani E; Cabras MG; Zanni M; Tilly H; Tessoulin B; Conconi A; Palombi F; Cavallo F; Morschhauser F; Gressin R; Marino D; et alii...

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study. in Leukemia / Leukemia. 2023 Feb;37(2):433-440. doi: 10.1038/s41375-022-01780-1. Epub 2023 Jan 18.

2023
AOU Alessandria
AOU Città della Salute di Torino

Bermema A; Cavallo F; Magagnoli M; Arcaini L; Leonardi F; Bruna R; Patti C; Ballerini F; Musuraca G; Benedetti F; Volpetti S; Celli M; Flenghi L; Ilariucci F; Zilioli VR; Arcari A; Rossi FG; Ghiggi C; Ciancia R; Zanni M; Pinto A; Castellino C; Stefoni V; Usai SV; Re A; Orsucci L; Evangelista A; Dodero A; Chiappella A; et alii...